Targeting TBL1 with tegavivint promotes anti-tumor and immunomodulatory responses in preclinical models of hepatocellular carcinoma

被引：0
|
作者：
Holloway, Kimberly R.
Drake, Thomas
Bird, Thomas
Horrigan, Stephen
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-6167
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6167
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma
    Wei-De Wu
    Pin-Shern Chen
    Hany A. Omar
    El-Shaimaa A. Arafa
    Hung-Wei Pan
    Jingyueh Jeng
    Jui-Hsiang Hung
    Scientific Reports, 8
  • [22] Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma
    Wu, Wei-De
    Chen, Pin-Shern
    Omar, Hany A.
    Arafa, El-Shaimaa A.
    Pan, Hung-Wei
    Jeng, Jingyueh
    Hung, Jui-Hsiang
    SCIENTIFIC REPORTS, 2018, 8
  • [23] Targeting cancer cells and anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma in vivo
    Qin, Jianmin
    CANCER RESEARCH, 2012, 72
  • [24] Erythromycin repurposing for hepatocellular carcinoma treatment: Targeting CD24 to enhance anti-tumor immunity
    Shao, Mingguang
    Zhao, Tiesuo
    Qian, Li
    Jia, Xiaolong
    Chen, Zhihan
    Wang, Kangle
    Sun, Yuanli
    Dong, Xiaoyu
    Geng, Jiaxin
    Zhang, Yongxi
    Guo, Sheng
    Yang, Zishan
    Wei, Tian
    Jia, Huijie
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 998
  • [25] Statin drugs have anti-tumor activity and enhance responses to anti-PD-1 therapy in preclinical models of head and neck cancer
    Burnham, Andre J.
    Kansal, Vikash
    Kinney, Brendan L.
    Paulos, Chrystal M.
    Lesinski, Gregory B.
    Saba, Nabil F.
    Schmitt, Nicole C.
    CANCER RESEARCH, 2022, 82 (12)
  • [26] Targeting 4-1BB in tumors enhances anti-tumor immune responses
    Weber, Amy Mackay
    Innamarato, Patrick
    Morse, Jennifer
    Kidd, Scott
    Asby, Sarah
    Sarnaik, Amod
    Pilon-Thomas, Shari
    CANCER RESEARCH, 2019, 79 (13)
  • [27] Anti-tumor activity of cisplatin is enhanced by PD-1 blockade in preclinical models of head and neck squamous cell carcinoma
    Tran, Linda
    Allen, Clint T.
    Park, So-Jin
    Xiao, Roy
    Van Waes, Carter
    Schmitt, Nicole C.
    CANCER RESEARCH, 2017, 77
  • [28] Combining Photodynamic Therapy with Immunostimulatory Nanoparticles Elicits Effective Anti-Tumor Immune Responses in Preclinical Murine Models
    't Veld, Ruben Victor Huis In
    Da Silva, Candido G.
    Jager, Martine J.
    Cruz, Luis J.
    Ossendorp, Ferry
    PHARMACEUTICS, 2021, 13 (09)
  • [29] Anti-tumor and immune effects of olaparib plus /- anti-PD-L1 in preclinical BRCA1mut tumor models
    Staniszewska, Anna
    Armenia, Joshua
    King, Matthew
    Michaloglou, Chrysiis
    Singh, Maneesh
    San Martin, Maryann
    Wilson, Zena
    Proia, Theresa
    Delpuech, Oona
    O'Connor, Mark
    Leo, Elisabetta
    Valge-Archer, Viia
    CANCER RESEARCH, 2020, 80 (16)
  • [30] Anti-Tumor Effects of Metformin in Animal Models of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
    Li, Juan
    Hernanda, Pratika Y.
    Bramer, Wichor M.
    Peppelenbosch, Maikel P.
    van Luijk, Judith
    Pan, Qiuwei
    PLOS ONE, 2015, 10 (06):
12345